Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upstream High Bolus Dose Tirofiban in STEMI (TISP)
NCT04111289Phase 2Unknown
- Sponsor
- Assiut University
- Start
- Nov 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of tirofiban in ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Assiut University. Primary endpoint: Short-term clinical outcome at 40 days. Status: unknown.
02
Drugs
tirofiban
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT04111289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04111289.